Golden
Daré Bioscience

Daré Bioscience

Daré Bioscience is a clinical-stage biopharmaceutical company offering products for women’s reproductive health.

Dare Bioscience offers women’s reproductive health devices, therapeutics and diagnostics and provides contraception, vaginal health, pain and fertility products. Two products in clinical development include Ovaprene, a non-hormonal monthly contraceptive ring and SST-6007 (5% Topical Sildenafil Citrate Cream), containing the same active ingredient in Viagra in a proprietary cram formulation for treating Female Sexual Arousal Disorder. 



Dare Bioscience acquired Cerulean Pharma, a nanotechnology-based therapeutics company in 2017. In 2018 Dare Bioscience entered a merger with Pear Tree Pharmaceuticals that includes securing rights to PT-101, a vaginal formulation of tamoxifen as a treatment for vulvar and vaginal atrophy in hormone-receptor-positive breast cancer patients. 



Timeline

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References